查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1839267

新一代抗体疗法市场分析及预测（至2034年）：类型、产品、技术、应用、製程、最终用户、阶段、部署、功能、模式

Next Generation Antibody Therapeutics Market Analysis and Forecast to 2034: Type, Product, Technology, Application, Process, End User, Stage, Deployment, Functionality, Mode
出版日期: | 出版商: Global Insight Services | 英文 336 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计新一代抗体疗法市场将从2024年的36亿美元成长到2034年的94亿美元，复合年增长率约为10.1%。新一代抗体疗法市场涵盖旨在提高疾病治疗特异性、疗效和安全性的先进生物製药，包括双特异性抗体、抗体药物复合体和工程化抗体片段。在分子工程创新和精准医疗的推动下，该市场预计将在肿瘤学、免疫学和感染疾病领域取得重大进展，满足尚未满足的医疗需求并拓展治疗应用。

新一代抗体疗法市场正经历强劲成长，这主要得益于生技和精准医疗的进步。单株抗体因其在多种疾病标靶治疗中的有效性而备受关注。双特异性抗体具有双重靶向能力，因其在癌症治疗方面的潜力而日益受到重视，并成为增长第二快的细分市场。抗体药物复合体）也正在崛起，成为重要的细分市场，它将抗体的特异性与强效细胞毒性药物结合。肿瘤治疗领域仍是成长最快的领域，反映出市场对创新癌症疗法的旺盛需求。自体免疫疾病紧随其后，受益于旨在调节免疫反应的新型抗体疗法的开发。抗体工程和抗体生产技术的改进等技术进步正在推动市场成长。对个人化医疗的日益重视正在推动对客製化抗体疗法的需求。製药公司之间的策略合作与伙伴关係正在促进创新并拓展治疗产品线。监管支持和快速核准流程进一步强化了市场活力，促进了新型抗体疗法的上市。

市场区隔
类型 单株抗体、双特异性抗体、抗体药物复合体、抗体片段、多株多株抗体
产品 治疗性抗体、诊断性抗体、研究性抗体、抗体片段
科技 噬菌体展示、融合瘤、基因转殖小鼠、细菌展示、酵母展示、哺乳动物细胞展示
目的 肿瘤科、自体免疫疾病、感染疾病、心血管疾病、神经系统疾病、代谢性疾病
流程 发现、开发、生产、品管、监管核准
最终用户 製药公司、生技公司、研究机构、受託研究机构
步 临床前试验、临床试验与商业化
部署 内部、外包
功能 标靶治疗、免疫疗法、偶联
模式 静脉注射、皮下注射、肌肉注射、口服

市场概述

新一代抗体疗法市场正经历着剧烈的变革，创新企业推出的先进疗法占据了市场主导地位。定价策略竞争激烈，反映出市场对更有效、更具标靶性的治疗方案的强劲需求。随着各公司努力满足未被满足的医疗需求并提高治疗效果，新产品上市数量迅速成长，市场呈现这样的特征。旨在加速产品开发和市场准入的策略联盟和伙伴关係进一步加剧了这种竞争格局。在竞争基准化分析方面，主要企业不断创新以保持竞争力。北美和欧洲严格的监管准则正在影响市场动态，其中监管因素发挥关键作用。监管环境正在不断演变，旨在提高治疗药物开发的透明度和安全性。各公司正大力投资研发，以有效应对这些监管要求。随着市场的不断成熟，抗体工程和新型递送平台的进步有望推动市场显着成长，并为相关人员带来丰厚的利润机会。

主要趋势和驱动因素：

新一代抗体疗法市场正经历强劲成长，这主要得益于生技和个人化医疗的突破性进展。关键趋势包括双特异性抗体的开发，这种抗体能够增强标靶能力和治疗效果。抗体药物复合体（ADC）的兴起正在革新癌症治疗，它能将细胞毒性药物直接递送至癌细胞，并最大限度地减少附带损伤。用于治疗自体免疫疾病的单株抗体也日益受到关注，这反映了市场对标靶治疗的需求。推动市场成长的因素包括抗体工程技术的进步以及慢性病盛行率的不断上升。监管核准的加快也有利于市场扩张。此外，生物技术公司与研究机构之间的合作正在促进创新并加速开发平臺。新兴市场也蕴藏着大量机会，这些市场拥有完善的医疗基础设施，并且对先进疗法的需求不断增长。那些投资于强大的研发和策略伙伴关係的公司将更有利于掌握这些快速成长的机会。

限制与挑战：

新一代抗体疗法市场面临许多重大限制和挑战。其中一个主要限制因素是高昂的研发和生产成本，这对中小企业而言可能难以承受，并限制了其进入市场。这种经济壁垒往往使市场力量集中在少数几家大型公司手中，扼杀了创新。监管障碍也构成了巨大的挑战。新疗法的严格核准流程会延缓市场进入并增加成本。这种法规环境要求进行大量的临床试验，而这些试验则耗时且耗力。抗体生产的复杂性也带来了挑战。生产这些疗法需要先进的技术和专业知识，难以有效率地扩大生产规模。这种复杂性可能导致产品品质不稳定和供应链问题。来自传统疗法的竞争进一步阻碍了市场渗透。许多医疗服务提供者和患者仍然依赖现有治疗方法，这减缓了新抗体药物的普及。最后，智慧财产权和专利纠纷也会阻碍市场成长。围绕专有技术的法律纠纷充斥着竞争激烈的市场环境，分散了研发资源。

关键人物

MacroGenics、ImmunoGen、MorphoSys、Genmab、Pieris Pharmaceuticals、AbCellera、Xencor、Adimab、MabSpace Biosciences、Harbor BioMed、Zymeworks、Bicycle Therapeutics、Crescendo Biologics、Mabion、I-Mab。

目录

第一章新一代抗体疗法市场概述

  • 调查目的
  • 新一代抗体疗法市场定义和范围
  • 报告局限性
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章：新一代抗体疗法市场展望

  • 新一代抗体疗法市场区隔
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章新一代抗体疗法市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状态
  • 供应链分析
  • 竞争产品分析
  • 最新进展

第六章：新一代抗体疗法的市场规模

  • 以价值计算的新一代抗体疗法市场规模
  • 新一代抗体疗法市场规模（按销售量计）

第七章新一代抗体疗法市场（按类型划分）

  • 市场概览
  • 单株抗体
  • 双特异性抗体
  • 抗体药物复合体
  • 抗体片段
  • 多株抗体
  • 其他的

第八章新一代抗体疗法市场：按产品划分

  • 市场概览
  • 治疗性抗体
  • 诊断抗体
  • 研究抗体
  • 抗体片段
  • 其他的

第九章新一代抗体疗法市场：依技术划分

  • 市场概览
  • 噬菌体展示
  • 融合瘤
  • 基因改造小鼠
  • 细菌展示
  • 酵母展示
  • 哺乳动物细胞展示
  • 其他的

第十章新一代抗体疗法市场：按应用领域划分

  • 市场概览
  • 肿瘤学
  • 自体免疫疾病
  • 感染疾病
  • 心血管疾病
  • 神经系统疾病
  • 代谢性疾病
  • 其他的

第十一章 依製程分類的新一代抗体疗法市场

  • 市场概览
  • 药物发现
  • 发展
  • 製造业
  • 品管
  • 药品核准
  • 其他的

第十二章新一代抗体疗法市场（按最终用户划分）

  • 市场概览
  • 製药公司
  • 生技公司
  • 研究所
  • 受託研究机构
  • 其他的

第十三章新一代抗体疗法市场（按阶段划分）

  • 市场概览
  • 临床前试验
  • 临床试验
  • 商业化
  • 其他的

第十四章新一代抗体疗法市场：依发展阶段划分

  • 市场概览
  • 内部
  • 外包
  • 其他的

第十五章新一代抗体疗法市场：按功能划分

  • 市场概览
  • 标靶治疗
  • 免疫疗法
  • 共轭
  • 其他的

第十六章新一代抗体疗法市场（按模式划分）

  • 市场概览
  • 静脉注射
  • 皮下注射
  • 肌肉内注射
  • 口服
  • 其他的

第十七章新一代抗体疗法市场（按地区划分）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十八章 竞争格局

  • 概述
  • 市占率分析
  • 主要企业的定位
  • 衝突领导力图谱
  • 供应商基准化分析
  • 发展策略基准化分析

第十九章：公司简介

  • MacroGenics
  • ImmunoGen
  • MorphoSys
  • Genmab
  • Pieris Pharmaceuticals
  • AbCellera
  • Xencor
  • Adimab
  • MabSpace Biosciences
  • Harbour BioMed
  • Zymeworks
  • Bicycle Therapeutics
  • Crescendo Biologics
  • Mabion
  • I-Mab
简介目录
Product Code: GIS34082

Next Generation Antibody Therapeutics Market is anticipated to expand from $3.6 billion in 2024 to $9.4 billion by 2034, growing at a CAGR of approximately 10.1%. The Next Generation Antibody Therapeutics Market encompasses advanced biologic drugs engineered to enhance specificity, efficacy, and safety in treating diseases. This includes bispecific antibodies, antibody-drug conjugates, and engineered antibody fragments. Driven by innovations in molecular engineering and a focus on precision medicine, this market promises significant advancements in oncology, immunology, and infectious diseases, addressing unmet medical needs and expanding therapeutic applications.

The Next Generation Antibody Therapeutics Market is experiencing robust growth, propelled by advancements in biotechnology and precision medicine. Monoclonal antibodies lead the market, driven by their efficacy in targeted therapies for various diseases. Bispecific antibodies, offering dual-targeting capabilities, are the second-highest performing sub-segment, gaining traction for their potential in oncology treatments. Antibody-drug conjugates are also emerging as a critical segment, combining antibody specificity with potent cytotoxic agents. The oncology therapeutic area remains the top-performing segment, reflecting the high demand for innovative cancer treatments. Autoimmune diseases follow, benefiting from the development of novel antibody therapies aimed at modulating immune responses. Technological advancements, such as improved antibody engineering and production techniques, are accelerating market growth. The increasing focus on personalized medicine is driving demand for tailored antibody therapies. Strategic collaborations and partnerships among pharmaceutical companies are fostering innovation and expanding the therapeutic pipeline. Regulatory support and expedited approval processes further enhance market dynamics, facilitating the introduction of novel antibody therapeutics.

Market Segmentation
TypeMonoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Antibody Fragments, Polyclonal Antibodies
ProductTherapeutic Antibodies, Diagnostic Antibodies, Research Antibodies, Antibody Fragments
TechnologyPhage Display, Hybridoma, Transgenic Mouse, Bacterial Display, Yeast Display, Mammalian Cell Display
ApplicationOncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases
ProcessDiscovery, Development, Manufacturing, Quality Control, Regulatory Approval
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations
StagePreclinical, Clinical Trials, Commercialized
DeploymentIn-House, Outsourced
FunctionalityTargeted Therapy, Immunotherapy, Conjugation
ModeIntravenous, Subcutaneous, Intramuscular, Oral

Market Snapshot:

Next Generation Antibody Therapeutics Market is witnessing a dynamic shift, with market share being dominated by innovative companies launching advanced therapeutics. Pricing strategies remain competitive, reflecting the high demand for more effective and targeted treatments. The market is characterized by a surge in new product launches, as companies strive to address unmet medical needs and enhance therapeutic efficacy. This competitive landscape is further invigorated by strategic collaborations and partnerships that aim to accelerate product development and market entry. In terms of competition benchmarking, key players are continuously innovating to maintain their competitive edge. Regulatory influences play a significant role, with stringent guidelines in North America and Europe impacting market dynamics. The regulatory landscape is evolving, encouraging transparency and safety in therapeutic development. Companies are investing heavily in research and development to navigate these regulations effectively. As the market continues to mature, advancements in antibody engineering and novel delivery platforms are expected to drive substantial growth, offering lucrative opportunities for stakeholders.

Geographical Overview:

The Next Generation Antibody Therapeutics Market is witnessing robust growth across various regions, each presenting unique opportunities. North America leads the market, propelled by substantial investments in biotechnology and a strong focus on innovative therapeutic solutions. The presence of major pharmaceutical companies and research institutions further bolsters the region's market dominance. Europe follows closely, with significant government support for biotechnological research and a well-established healthcare infrastructure. The region's emphasis on personalized medicine and advanced therapeutics enhances its market potential. In Asia Pacific, the market is expanding rapidly, driven by increasing healthcare expenditure and a growing focus on precision medicine. Countries like China and India are emerging as key players, with rising investments in biopharmaceutical research and development. Latin America and the Middle East & Africa are burgeoning markets with increasing potential. Brazil and Saudi Arabia are witnessing a surge in biotechnology investments, recognizing the importance of next-generation antibody therapeutics in advancing healthcare outcomes.

Key Trends and Drivers:

The Next Generation Antibody Therapeutics Market is experiencing robust growth driven by breakthroughs in biotechnology and personalized medicine. Key trends include the development of bispecific antibodies, which enhance targeting capabilities and therapeutic efficacy. The rise of antibody-drug conjugates (ADCs) is revolutionizing cancer treatment by delivering cytotoxic agents directly to cancer cells, minimizing collateral damage. The market is also witnessing an increased focus on monoclonal antibodies for autoimmune diseases, reflecting the demand for targeted therapies. Drivers include technological advancements in antibody engineering and a growing prevalence of chronic diseases. Regulatory approvals are accelerating, providing a favorable landscape for market expansion. Moreover, collaborations between biotech firms and research institutions are fostering innovation and expediting the development pipeline. Opportunities abound in emerging markets, where healthcare infrastructure is improving, and demand for advanced therapeutics is rising. Companies investing in robust R&D and strategic partnerships are well-positioned to capitalize on these burgeoning opportunities.

Restraints and Challenges:

The Next Generation Antibody Therapeutics Market is confronted with several significant restraints and challenges. One primary restraint is the high cost of development and production, which can be prohibitive for smaller companies and limit market entry. This financial barrier often results in a concentration of market power among a few large players, stifling innovation. Regulatory hurdles present another formidable challenge. The stringent approval processes for new therapeutics can delay market entry and increase costs. This regulatory environment demands extensive clinical trials, which are both time-consuming and expensive. The complexity of antibody production also poses a challenge. Manufacturing these therapeutics requires advanced technology and expertise, which can be difficult to scale efficiently. This complexity can lead to variability in product quality and supply chain issues. Market penetration is further hindered by competition from traditional therapies. Many healthcare providers and patients remain loyal to established treatments, slowing the adoption of new antibody therapeutics. Lastly, intellectual property and patent disputes can impede market growth. The competitive landscape is fraught with legal battles over proprietary technologies, diverting resources from research and development.

Key Players:

MacroGenics, ImmunoGen, MorphoSys, Genmab, Pieris Pharmaceuticals, AbCellera, Xencor, Adimab, MabSpace Biosciences, Harbour BioMed, Zymeworks, Bicycle Therapeutics, Crescendo Biologics, Mabion, I-Mab

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Next Generation Antibody Therapeutics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Next Generation Antibody Therapeutics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by Process
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Stage
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by Functionality
  • 2.12 Key Highlights of the Market, by Mode
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by Process
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Stage
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by Functionality
  • 3.11 Market Attractiveness Analysis, by Mode
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Next Generation Antibody Therapeutics Market Outlook

  • 4.1 Next Generation Antibody Therapeutics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Next Generation Antibody Therapeutics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Next Generation Antibody Therapeutics Market Size

  • 6.1 Next Generation Antibody Therapeutics Market Size, by Value
  • 6.2 Next Generation Antibody Therapeutics Market Size, by Volume

7: Next Generation Antibody Therapeutics Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Bispecific Antibodies
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Antibody-Drug Conjugates
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Antibody Fragments
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Polyclonal Antibodies
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Others
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region

8: Next Generation Antibody Therapeutics Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Antibodies
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Diagnostic Antibodies
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Research Antibodies
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Antibody Fragments
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Next Generation Antibody Therapeutics Market, by Technology

  • 9.1 Market Overview
  • 9.2 Phage Display
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Hybridoma
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Transgenic Mouse
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Bacterial Display
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Yeast Display
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Mammalian Cell Display
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Next Generation Antibody Therapeutics Market, by Application

  • 10.1 Market Overview
  • 10.2 Oncology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Autoimmune Diseases
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Infectious Diseases
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Cardiovascular Diseases
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Neurological Diseases
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Metabolic Diseases
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Next Generation Antibody Therapeutics Market, by Process

  • 11.1 Market Overview
  • 11.2 Discovery
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Development
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Manufacturing
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Quality Control
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Regulatory Approval
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: Next Generation Antibody Therapeutics Market, by End User

  • 12.1 Market Overview
  • 12.2 Pharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Contract Research Organizations
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Next Generation Antibody Therapeutics Market, by Stage

  • 13.1 Market Overview
  • 13.2 Preclinical
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Clinical Trials
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Commercialized
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Next Generation Antibody Therapeutics Market, by Deployment

  • 14.1 Market Overview
  • 14.2 In-House
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Outsourced
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Next Generation Antibody Therapeutics Market, by Functionality

  • 15.1 Market Overview
  • 15.2 Targeted Therapy
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Immunotherapy
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Conjugation
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Next Generation Antibody Therapeutics Market, by Mode

  • 16.1 Market Overview
  • 16.2 Intravenous
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Subcutaneous
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Intramuscular
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Oral
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region
  • 16.6 Others
    • 16.6.1 Key Market Trends & Opportunity Analysis
    • 16.6.2 Market Size and Forecast, by Region

17: Next Generation Antibody Therapeutics Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by Process
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Stage
    • 17.2.9 North America Market Size and Forecast, by Deployment
    • 17.2.10 North America Market Size and Forecast, by Functionality
    • 17.2.11 North America Market Size and Forecast, by Mode
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by Process
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Stage
      • 17.2.9.8 United States Market Size and Forecast, by Deployment
      • 17.2.9.9 United States Market Size and Forecast, by Functionality
      • 17.2.9.10 United States Market Size and Forecast, by Mode
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by Process
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Stage
      • 17.2.10.8 Canada Market Size and Forecast, by Deployment
      • 17.2.10.9 Canada Market Size and Forecast, by Functionality
      • 17.2.10.10 Canada Market Size and Forecast, by Mode
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by Process
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Stage
    • 17.3.9 Europe Market Size and Forecast, by Deployment
    • 17.3.10 Europe Market Size and Forecast, by Functionality
    • 17.3.11 Europe Market Size and Forecast, by Mode
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by Process
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Stage
      • 17.3.10.8 Germany Market Size and Forecast, by Deployment
      • 17.3.10.9 Germany Market Size and Forecast, by Functionality
      • 17.3.10.10 Germany Market Size and Forecast, by Mode
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by Process
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Stage
      • 17.3.11.8 France Market Size and Forecast, by Deployment
      • 17.3.11.9 France Market Size and Forecast, by Functionality
      • 17.3.11.10 France Market Size and Forecast, by Mode
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by Process
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Stage
      • 17.3.12.8 Spain Market Size and Forecast, by Deployment
      • 17.3.12.9 Spain Market Size and Forecast, by Functionality
      • 17.3.12.10 Spain Market Size and Forecast, by Mode
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by Process
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Stage
      • 17.3.13.8 Italy Market Size and Forecast, by Deployment
      • 17.3.13.9 Italy Market Size and Forecast, by Functionality
      • 17.3.13.10 Italy Market Size and Forecast, by Mode
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by Process
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.9 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.10 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by Process
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Stage
      • 17.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.9 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.10 Sweden Market Size and Forecast, by Mode
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by Process
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.9 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.10 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by Process
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Stage
      • 17.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.9 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.10 Denmark Market Size and Forecast, by Mode
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by Process
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Stage
      • 17.3.18.8 Finland Market Size and Forecast, by Deployment
      • 17.3.18.9 Finland Market Size and Forecast, by Functionality
      • 17.3.18.10 Finland Market Size and Forecast, by Mode
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by Process
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Stage
      • 17.3.19.8 Russia Market Size and Forecast, by Deployment
      • 17.3.19.9 Russia Market Size and Forecast, by Functionality
      • 17.3.19.10 Russia Market Size and Forecast, by Mode
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by Process
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Stage
      • 17.4.9.8 China Market Size and Forecast, by Deployment
      • 17.4.9.9 China Market Size and Forecast, by Functionality
      • 17.4.9.10 China Market Size and Forecast, by Mode
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by Process
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Stage
      • 17.4.10.8 India Market Size and Forecast, by Deployment
      • 17.4.10.9 India Market Size and Forecast, by Functionality
      • 17.4.10.10 India Market Size and Forecast, by Mode
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by Process
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Stage
      • 17.4.11.8 Japan Market Size and Forecast, by Deployment
      • 17.4.11.9 Japan Market Size and Forecast, by Functionality
      • 17.4.11.10 Japan Market Size and Forecast, by Mode
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by Process
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Stage
      • 17.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.9 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.10 South Korea Market Size and Forecast, by Mode
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by Process
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Stage
      • 17.4.13.8 Australia Market Size and Forecast, by Deployment
      • 17.4.13.9 Australia Market Size and Forecast, by Functionality
      • 17.4.13.10 Australia Market Size and Forecast, by Mode
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by Process
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Stage
      • 17.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.9 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.10 Singapore Market Size and Forecast, by Mode
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by Process
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.9 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.10 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by Process
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.9 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.10 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by Process
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.9 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.10 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by Process
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Stage
    • 17.5.9 Latin America Market Size and Forecast, by Deployment
    • 17.5.10 Latin America Market Size and Forecast, by Functionality
    • 17.5.11 Latin America Market Size and Forecast, by Mode
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by Process
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Stage
      • 17.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.9 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.10 Brazil Market Size and Forecast, by Mode
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by Process
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Stage
      • 17.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.9 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.10 Mexico Market Size and Forecast, by Mode
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by Process
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Stage
      • 17.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.9 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.10 Argentina Market Size and Forecast, by Mode
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by Process
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Stage
      • 17.6.10.8 UAE Market Size and Forecast, by Deployment
      • 17.6.10.9 UAE Market Size and Forecast, by Functionality
      • 17.6.10.10 UAE Market Size and Forecast, by Mode
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by Process
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Stage
      • 17.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.9 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.10 South Africa Market Size and Forecast, by Mode
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 MacroGenics
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 ImmunoGen
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 MorphoSys
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Genmab
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Pieris Pharmaceuticals
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 AbCellera
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Xencor
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Adimab
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 MabSpace Biosciences
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Harbour BioMed
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Zymeworks
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Bicycle Therapeutics
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Crescendo Biologics
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Mabion
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 I-Mab
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis